BioCentury
ARTICLE | Company News

Kinetek, atugen GeneBloc deal

February 20, 2002 8:00 AM UTC

atugen (Berlin, Germany) will use its GeneBloc and cellular delivery technologies to knock-down the expression of signal transduction kinase targets supplied by Kinetek (Vancover, B.C.). Kinetek then ...